[1]马林科,马守成.阿莫西林联合不同铋剂四联方案治疗对海原地区幽门螺杆菌感染患者幽门螺杆菌根除率及不良反应的影响[J].医学信息,2025,38(24):132-136.[doi:10.3969/j.issn.1006-1959.2025.24.027]
　MA Linke,MA Shoucheng.Effect of Amoxicillin Combined with Different Bismuth Quadruple Regimenson Helicobacter Pylori Eradication Rate and Adverse Reactions in Patientswith Helicobacter Pylori Infection in Haiyuan Area[J].Journal of Medical Information,2025,38(24):132-136.[doi:10.3969/j.issn.1006-1959.2025.24.027]
点击复制

阿莫西林联合不同铋剂四联方案治疗对海原地区幽门螺杆菌感染患者幽门螺杆菌根除率及不良反应的影响()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年24期
页码:
132-136
栏目:
论著
出版日期:
2025-12-15

文章信息/Info

Title:
Effect of Amoxicillin Combined with Different Bismuth Quadruple Regimenson Helicobacter Pylori Eradication Rate and Adverse Reactions in Patientswith Helicobacter Pylori Infection in Haiyuan Area
文章编号:
1006-1959（2025）24-0132-05
作者:
马林科; 马守成
宁夏回族自治区人民医院/宁夏医科大学附属自治区人民医院消化内科，宁夏 银川 750002
Author(s):
MA Linke;  MA Shoucheng
Department of Gastroenterology, People′s Hospital of Ningxia Hui Autonomous Region/People′s Hospital of Autonomous Region Affiliated to Ningxia Medical University, Yinchuan 750002, Ningxia, China
关键词:
阿莫西林; 铋剂; 四联方案; 幽门螺杆菌; 免疫功能; 炎性因子; 海原地区
Keywords:
Amoxicillin;  Bismuth;  Quadruple scheme;  Helicobacter pylori;  Immune function;  Inflammatory factors;  Haiyuan area
分类号:
R573
DOI:
10.3969/j.issn.1006-1959.2025.24.027
文献标志码:
A
摘要:
目的 探讨阿莫西林联合不同铋剂四联方案治疗海原地区幽门螺杆菌（Hp）感染患者的效果，分析该方案对患者Hp根除率及不良反应的影响。方法 选取2023年2月-10月宁夏回族自治区人民医院收治的75例海原地区Hp感染患者作为研究对象，按照治疗方案不同分为米诺环素组（44例）和左氧氟沙星组（31例）。两组均给予阿莫西林+艾司奥美拉唑+果胶铋基础治疗，米诺环素组在此基础上加用米诺环素治疗，左氧氟沙星组加用左氧氟沙星治疗。比较两组临床疗效及Hp根除率、免疫功能指标（CD4+、CD4+/CD8+、CD8+）、炎性因子水平[白细胞介素-6（IL-6）、肿瘤坏死因子-α（TNF-α）、C反应蛋白（CRP）]及不良反应发生率。结果 米诺环素组总有效率（93.18%）、Hp根除率（90.91%）均高于左氧氟沙星组（80.65%、74.19%）（P＜0.05）。治疗后，两组CD4+、CD4+/CD8+均较治疗前升高，CD8+较治疗前降低，且米诺环素组CD4+、CD4+/CD8+高于左氧氟沙星组，CD8+低于左氧氟沙星组（P＜0.05）。治疗后，两组IL-6、TNF-α、CRP均较治疗前降低，且米诺环素组IL-6、TNF-α、CRP低于左氧氟沙星组（P＜0.05）。米诺环素组不良反应发生率（9.09%）低于左氧氟沙星组（22.58%），但差异无统计学意义（χ2=3.128，P=0.077）。结论 阿莫西林联合艾司奥美拉唑+果胶铋+米诺环素四联方案治疗海原地区Hp感染患者的Hp根除率更高，能改善患者免疫功能，减轻炎症反应，且安全性良好，更适合作为该地区的治疗方案。
Abstract:
Objective To investigate the effect of amoxicillin combined with different bismuth quadruple regimens in the treatment of patients with Helicobacter pylori (Hp) infection in Haiyuan area, and to analyze the effect of this regimen on Hp eradication rate and adverse reactions. Methods A total of 75 patients with Hp infection in Haiyuan area admitted to People′s Hospital of Ningxia Hui Autonomous Region from February to October 2023 were selected as the research objects. According to different treatment schemes, they were divided into minocycline group (44 patients) and levofloxacin group (31 patients). Both groups were given amoxicillin+esomeprazole magnesium+bismuth pectin basic treatment. The minocycline group was treated with minocycline on this basis, and the levofloxacin group was treated with levofloxacin. The clinical efficacy, Hp eradication rate, immune function indexes (CD4+, CD4+/CD8+, CD8+), inflammatory factor levels [interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive protein (CRP)] and incidence of adverse reactions were compared between the two groups. Results The total effective rate (93.18%) and Hp eradication rate (90.91%) of minocycline group were higher than those of levofloxacin group (80.65%, 74.19%) (P<0.05). After treatment, CD4+ and CD4+/CD8+ in the two groups were higher than those before treatment, CD8+ was lower than that before treatment, and CD4+ and CD4+/CD8+ in the minocycline group were higher than those in the levofloxacin group, CD8+ was lower than that in the levofloxacin group (P<0.05). After treatment, IL-6, TNF-α and CRP in the two groups were lower than those before treatment, and IL-6, TNF-α and CRP in the minocycline group were lower than those in the levofloxacin group (P<0.05). The incidence of adverse reactions in minocycline group (9.09%) was lower than that in levofloxacin group (22.58%), but the difference was not statistically significant (χ2=3.128, P=0.077). Conclusion Amoxicillin combined with esomeprazole magnesium+bismuthpectin+minocycline quadruple regimen has a higher eradication rate of Hp in patients with Hp infection in Haiyuan area. Meanwhile, it can improve the immune function of patients, reduce the inflammatory response, and has good safety. It is more suitable as a treatment plan in this area.

参考文献/References:

[1]朱健伟,徐鹏,王佳艳,等.雷贝拉唑联合阿莫西林高剂量二联疗法与铋剂四联疗法根除幽门螺杆菌感染有效性和安全性的比较研究[J].胃肠病学,2022,27(1):17-20.[2]赵京平,王誉敏,游云龙,等.艾司奥美拉唑联合阿莫西林方案与含铋剂四联方案对幽门螺杆菌感染初治患者的疗效比较[J].实用临床医药杂志,2022,26(12):51-55,60.[3]杨小红,杨海涛,刘超,等.含阿莫西林克拉维酸钾的铋剂四联方案治疗幽门螺杆菌感染致慢性胃炎的有效性及安全性观察[J].药物评价研究,2022,45(9):1863-1869.[4]张月霞,张灵云,蓝宇,等.含米诺环素及左氧氟沙星的铋剂四联方案在幽门螺杆菌感染患者中的应用[J].中国医药,2025,20(7):1014-1018.[5]王烁,彭芸,曾小明,等.铋剂四联10天疗法联合酪酸梭菌、聚普瑞锌治疗幽门螺杆菌感染的疗效分析[J].中国现代医学杂志,2021,31(24):32-36.[6]刘林,陈智颖,宋学诗,等.荜铃胃痛颗粒替代铋剂组成四联疗法根除幽门螺杆菌感染的疗效观察[J].中国中西医结合消化杂志,2025,33(5):549-552,557.[7]郭涛,王强,吴晰,等.阿莫西林和克拉霉素的铋剂四联方案作为初次根除幽门螺杆菌治疗的1年随访结果[J].中国医学科学院学报,2019,41(1):75-79.[8]邵俏俏,马菁,余雪纯,等.雷贝拉唑联合阿莫西林或呋喃唑酮二联疗法根除幽门螺杆菌感染的临床疗效研究[J].中国全科医学,2022,25(29):3640-3645.[9]蒋逸舟.伏诺拉生联合小剂量阿莫西林根除幽门螺杆菌的疗效分析[D].南京:南京医科大学,2024.[10]黄元龙,左后东,毛本红,等.伏诺拉生与阿莫西林二联方案根除幽门螺杆菌的真实世界研究[J].中国药房,2023,34(22):2775-2779.[11]张喆,郑长清.东方胃药联合铋剂四联疗法治疗幽门螺杆菌感染的疗效观察[J].实用药物与临床,2022,25(4):321-323.[12]叶长根,朱晓佳,胡娜,等.高剂量二联疗法根除幽门螺杆菌的疗效及安全性分析[J].世界华人消化杂志,2024,32(9):665-670.[13]郭媛,鲁瑶瑶,刘鑫,等.含米诺环素的铋剂四联方案根除幽门螺杆菌疗效的前瞻性观察研究[J].成都医学院学报,2023,18(1):79-82.[14]张亚芹,沙玉彪,贾春霞,等.香砂六君子汤联合铋剂四联疗法治疗幽门螺杆菌感染血液透析患者临床疗效及安全性观察[J].湖北中医药大学学报,2021,23(3):100-103.[15]于海燕,赵恒,樊贞瑜,等.利福昔明伏诺拉生新四联治疗难治性幽门螺杆菌感染[J].胃肠病学和肝病学杂志,2025,34(6):823-825.[16]甘鹏飞,杨红,彭书贤.益生菌联合含铋剂四联疗法对小儿幽门螺杆菌相关胃炎的影响[J].中国药物应用与监测,2025,22(3):480-485.[17]杨秋霞,侯灼,周秋烨,等.伏诺拉生联合阿莫西林二联方案初始根除幽门螺杆菌的疗效分析[J].胃肠病学,2024,29(10):621-624.[18]司小北,陈晓露,张灵云,等.不同含米诺环素四联方案在幽门螺杆菌感染初治患者中的疗效及卫生经济学评价[J].中国医药,2024,19(7):1019-1023.[19]唐丹,袁玲芝,岳纯,等.基于抗生素使用史的含铋剂四联方案对幽门螺杆菌的根除效果[J].中南大学学报(医学版),2018,43(7):772-778.

相似文献/References:

[1]罗宜辉,刘代华.益生菌联合四联方案根除幽门螺杆菌的临床研究[J].医学信息,2018,31(11):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
　LUO Yi-hui,LIU Dai-hua.Clinical Study on the Eradication of Helicobacter Pylori by Probiotics Combined with Quadruple Regimen[J].Journal of Medical Information,2018,31(24):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
[2]吕彤观.三联疗法治疗牙周病的临床效果观察[J].医学信息,2018,31(18):129.[doi:10.3969/j.issn.1006-1959.2018.18.041]
　LV Tong-guan.Clinical Observation of Triple Therapy for Periodontosis[J].Journal of Medical Information,2018,31(24):129.[doi:10.3969/j.issn.1006-1959.2018.18.041]
[3]刘敏芝,李运泽.幽门螺杆菌的治疗现状[J].医学信息,2021,34(15):35.[doi:10.3969/j.issn.1006-1959.2021.15.010]
　LIU Min-zhi,LI Yun-ze.Current Status of Treatment of Helicobacter Pylori[J].Journal of Medical Information,2021,34(24):35.[doi:10.3969/j.issn.1006-1959.2021.15.010]
[4]朱宝贤.阿莫西林联合强的松对非哺乳期乳腺炎患者免疫调节及炎性因子水平的影响[J].医学信息,2022,35(07):171.[doi:10.3969/j.issn.1006-1959.2022.07.045]
　ZHU Bao-xian.Effects of Amoxicillin Combined with Prednisone on Immune Regulation and Inflammatory Factors in Patients with Non-lactating Mastitis[J].Journal of Medical Information,2022,35(24):171.[doi:10.3969/j.issn.1006-1959.2022.07.045]
[5]黄 涛.含铋剂的四联疗法治疗消化性溃疡患者的临床疗效及对溃疡愈合、炎症因子的影响[J].医学信息,2024,37(16):55.[doi:10.3969/j.issn.1006-1959.2024.16.011]
　HUANG Tao.Clinical Efficacy of Bismuth-containing Quadruple Therapy in the Treatment of Patientswith Peptic Ulcer and its Effect on Ulcer Healing and Inflammatory Factors[J].Journal of Medical Information,2024,37(24):55.[doi:10.3969/j.issn.1006-1959.2024.16.011]
[6]李 桃.泮托拉唑、克拉霉素、阿莫西林与果胶铋四联疗法不同疗程治疗胃溃疡临床疗效的比较研究[J].医学信息,2025,38(09):121.[doi:10.3969/j.issn.1006-1959.2025.09.024]
　LI Tao.Comparative Study on the Clinical Efficacy of Pantoprazole, Clarithromycin, Amoxicillin and Bismuth Pectin Quadruple Therapy with Different Courses in the Treatment of Gastric Ulcer[J].Journal of Medical Information,2025,38(24):121.[doi:10.3969/j.issn.1006-1959.2025.09.024]
[7]邵糖根.阿莫西林联合奥美拉唑治疗胃炎合并胃溃疡的临床效果[J].医学信息,2025,38(13):135.[doi:10.3969/j.issn.1006-1959.2025.13.026]
　SHAO Tanggen.Clinical Effect of Amoxicillin Combined with Omeprazole in the Treatment of Gastritis Complicated with Gastric Ulcer[J].Journal of Medical Information,2025,38(24):135.[doi:10.3969/j.issn.1006-1959.2025.13.026]
[8]陈淑平,徐 铭,刘元东.替戈拉生联合高剂量阿莫西林二联方案根除治疗幽门螺杆菌的疗效观察[J].医学信息,2025,38(23):97.[doi:10.3969/j.issn.1006-1959.2025.23.019]
　CHEN Shuping,XU Ming,LIU Yuandong.Observation on the Efficacy of Tegoprazan and High-dose AmoxicillinDual Therapy for Eradicating Helicobacter Pylori[J].Journal of Medical Information,2025,38(24):97.[doi:10.3969/j.issn.1006-1959.2025.23.019]

更新日期/Last Update: 1900-01-01